From Wikipedia, the free encyclopedia
Jump to: navigation, search

The term "infectobesity" refers to obesity of infectious origin and the emerging field of medical research that studies the relationship between pathogens (disease-causing organisms, such as viruses and bacteria) and weight gain. The term was coined in 2001 by Dr. Nikhil V. Dhurandhar, at the Pennington Biomedical Research Center. (Dhurandhar, 2001).


The study of the effect of infectious agents on metabolism is still in its early stages. Gut flora has been shown to differ between lean and obese humans. There is an indication that gut flora in obese and lean individuals can affect the metabolic potential. This apparent alteration of the metabolic potential is believed to confer a greater capacity to harvest energy contributing to obesity. Whether these differences are the direct cause or the result of obesity has yet to be determined unequivocally.[1]


An association between viruses and obesity has been found in humans as well as a number of different animal species. The amount that these associations may have contributed to the rising rate of obesity is yet to be determined.[2]

The fat virus is the popular name for the concept that some obesity in humans and other animals has a viral source. The AD-36 adenovirus has been observed to increase the amount of body fat on laboratory animals,[3] an effect that has been duplicated on chickens[4] and monkeys.[5]

Ad-36 is known to cause obesity in chickens, mice, rats, and monkeys and was present in 30% of obese humans and 11% of non-obese humans. The prevalence of Adv36 positivity in lean individuals increased from ∼7% in 1992-1998 to 15-20% in 2002-2009, which paralleled the increase in obesity prevalence.

See also[edit]


  1. ^ DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE (April 2008). "Gut microbiota and its possible relationship with obesity". Mayo Clinic proceedings. Mayo Clinic 83 (4): 460–9. doi:10.4065/83.4.460. PMID 18380992. 
  2. ^ Falagas ME, Kompoti M (July 2006). "Obesity and infection". Lancet Infect Dis 6 (7): 438–46. doi:10.1016/S1473-3099(06)70523-0. PMID 16790384. 
  3. ^ Whigham, Leah D.; Barbara A. Israel; Richard L. Atkinson (2006). "Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals". Am J Physiol Regul Integr Comp Physiol 290: R190–4. doi:10.1152/ajpregu.00479.2005. PMID 16166204. 
  4. ^ Whigham, L.D.; Israel, B.A.; Atkinson, R.L. (2006). "Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals". American Journal of Physiology- Regulatory, Integrative and Comparative Physiology 290 (1): 190–194{{inconsistent citations}} 
  5. ^ Dhurandhar, N.V.; Whigham, L.D.; Abbott, D.H.; Schultz-darken, N.J.; Israel, B.A.; Bradley, S.M.; Kemnitz, J.W.; Allison, D.B.; Atkinson, R.L. (2002). "Human Adenovirus Ad-36 Promotes Weight Gain in Male Rhesus and Marmoset Monkeys 1 2". Journal of Nutrition 132 (10): 3155–3160. PMID 12368411{{inconsistent citations}} 

External links[edit]